Tags

Type your tag names separated by a space and hit enter

tildrakizumab

tildrakizumab is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

General

Pronunciation:
til-dra-kiz-ue-mab

Trade Name(s)

  • Ilumya

Ther. Class.
antipsoriatics

Pharm. Class.
interleukin antagonists
monoclonal antibodies

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

Quiring, Courtney, et al. "Tildrakizumab." Davis's Drug Guide, 16th ed., F.A. Davis Company, 2019. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110592/all/tildrakizumab.
Quiring C, Sanoski CA, Vallerand AH. Tildrakizumab. Davis's Drug Guide. 16th ed. F.A. Davis Company; 2019. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110592/all/tildrakizumab. Accessed August 17, 2019.
Quiring, C., Sanoski, C. A., & Vallerand, A. H. (2019). Tildrakizumab. In Davis's Drug Guide. Available from https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110592/all/tildrakizumab
Quiring C, Sanoski CA, Vallerand AH. Tildrakizumab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2019. [cited 2019 August 17]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110592/all/tildrakizumab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - tildrakizumab ID - 110592 A1 - Quiring,Courtney, AU - Sanoski,Cynthia A, AU - Vallerand,April Hazard, BT - Davis's Drug Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110592/all/tildrakizumab PB - F.A. Davis Company ET - 16 DB - Pediatrics Central DP - Unbound Medicine ER -